Literature DB >> 8868149

[Evaluation of a German version of WOMAC (Western Ontario and McMaster Universities) Arthrosis Index].

G Stucki1, D Meier, S Stucki, B A Michel, A G Tyndall, W Dick, R Theiler.   

Abstract

The WOMAC (Western Ontario and McMaster Universities) Osteoarthritis Index is a tested questionnaire to assess symptoms and physical functional disability. We adapted the WOMAC for the German language and tested its metric properties, test-retest reliability and validity in 51 patients with knee and hip OA. All WOMAC scales (pain, stiffness, function) were internally consistent with Cronbach's coefficient alpha ranging from 0.80 to 0.96. Test-retest reliability was satisfactory with intraclass correlation coefficients ranging from 0.55 to 0.74. All scales and the global index calculated as the mean of scale scores had a bimodal distribution and a slight ceiling effect. As hypothesized the WOMAC scales were associated with radiological OA-severity and limitations of range-of-motion. Patients with more severe symptoms and functional disability perceived more limitations in their roles at home and at work. The presented German version of the WOMAC is a reliable and valid instrument for the assessment of symptoms and physical functional disability in patients with knee and hip OA.

Entities:  

Mesh:

Year:  1996        PMID: 8868149

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  102 in total

1.  [Rehabilitation of rheumatic diseases].

Authors:  Ernst Wagner
Journal:  Wien Med Wochenschr       Date:  2003

2.  Inpatient rehabilitation for hip or knee osteoarthritis: 2 year follow up study.

Authors:  M Weigl; F Angst; G Stucki; S Lehmann; A Aeschlimann
Journal:  Ann Rheum Dis       Date:  2004-04       Impact factor: 19.103

3.  [Gait analysis after minimally invasive total hip arthroplasty].

Authors:  K Sander; F Layher; C Anders; A Roth; J Babisch; H-C Scholle; R W Kinne
Journal:  Orthopade       Date:  2012-05       Impact factor: 1.087

4.  Total hip replacement in congenital high hip dislocation following iliofemoral monotube distraction.

Authors:  Johannes Holinka; Martin Pfeiffer; Jochen G Hofstaetter; Richard Lass; Rainer I Kotz; Alexander Giurea
Journal:  Int Orthop       Date:  2010-03-29       Impact factor: 3.075

5.  The First SICOT Oral Presentation Award 2011: imageless computer-assisted femoral component positioning in hip resurfacing: a prospective randomised trial.

Authors:  Maik Stiehler; Jens Goronzy; Albrecht Hartmann; Frank Krummenauer; Klaus-Peter Günther
Journal:  Int Orthop       Date:  2013-02-06       Impact factor: 3.075

6.  Complications and patient satisfaction after periacetabular pelvic osteotomy.

Authors:  R Biedermann; L Donnan; A Gabriel; R Wachter; M Krismer; H Behensky
Journal:  Int Orthop       Date:  2007-06-20       Impact factor: 3.075

7.  Total knee arthroplasty using ultra-congruent inserts can provide similar stability and function compared with cruciate-retaining total knee arthroplasty.

Authors:  Eun-Kyoo Song; Hong-An Lim; Sang-Don Joo; Sung-Kyu Kim; Keun-Bae Lee; Jong-Keun Seon
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2017-04-24       Impact factor: 4.342

8.  Longitudinal changes in subchondral bone structure as assessed with MRI are associated with functional outcome after high tibial osteotomy.

Authors:  Alexandra S Gersing; Pia M Jungmann; Benedikt J Schwaiger; Julia Zarnowski; Felix K Kopp; Saskia Landwehr; Martin Sauerschnig; Gabby B Joseph; Andreas B Imhoff; Ernst J Rummeny; Jan S Kirschke; Thomas Baum
Journal:  J ISAKOS       Date:  2018-06-28

Review 9.  Practical assessment in patients suffering from musculoskeletal disorders.

Authors:  Mohammad Keilani; Andrew J Haig; Richard Crevenna
Journal:  Wien Med Wochenschr       Date:  2015-12-09

10.  Patient relevant outcome 7 years after total hip replacement for OA - a prospective study.

Authors:  Anna-K Nilsdotter; Fredrik Isaksson
Journal:  BMC Musculoskelet Disord       Date:  2010-03-11       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.